The Biotech Capital Compass
Biotechnology & ‘Fog of Valuation’ savant
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 182 | Founded | 2 years ago | Last Issue | 5 days ago |
| Active | |||||
Read this Newsletter
hartajsingh1.substack.comLatest Issues
Biotech Blueprint x Biotech Capital Compass Video Podcast
In this joint Biotech Blueprint and Biotech Capital Compass discussion, we revisit the rapidly evolving mRNA landscape several years after the pandemic-era peak of enthusiasm and controversy. The conversation explores Moderna’s transition f...
How BioPharma Works — Part 1: Roche and the Modern Pharma Defense Model
Free Video Companion
The Biotech Capital Compass has often written about biotech volatility, clinical readouts, innovation cycles, and the shifting behavior of healthcare equities. But stepping back, a broader question begins to emerg...
Biotech Tape Check: May 2026 Video Briefing
Watch now | Rates, volatility, and a sector trying to recover under uncertainty.
The inaugural monthly edition of Biotech Tape Check explores a biotechnology sector increasingly caught between improving fundamentals and worsening macro con...
The Skeptical Lens: Part 3, Thermo Fisher and the Infrastructure Layer Behind Modern BioPharma
How Thermo Fisher Became a Levered Proxy on Scientific Funding, Drug Development, and the Industrialization of Biology.
Thermo Fisher Scientific increasingly occupies a unique position within healthcare and biotechnology. Rather than under...
Biotech Tape Check: Rates, Volatility & Fragile Optimism
The biotechnology sector entered 2026 expecting a more constructive macro backdrop. Funding conditions were stabilizing, M&A discussions were re-emerging, and investors were increasingly willing to rotate back into higher-beta small- and mi...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for The Biotech Capital Compass.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Biotech Capital Compass breaks down complex biotech stories into valuation, risk, and narrative frameworks investors can use. Written by Hartaj Singh, a biotech analyst focused on translating innovation into investment reality.
Frequently Asked Questions
How can I access the email archive for The Biotech Capital Compass?
You can find recent issues that have been published by The Biotech Capital Compass on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Biotech Capital Compass have?
To see how many people subscribe to The Biotech Capital Compass, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Biotech Capital Compass?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Biotech Capital Compass as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Biotech Capital Compass?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Biotech Capital Compass using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to The Biotech Capital Compass?
Scroll up to where it says Related Newsletters to see other publications like The Biotech Capital Compass. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Biotech Capital Compass?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.